TheEdgeResearch
Home / Stocks / CHALF

Chalice Brands Ltd (CHALF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +0.00%
Market Cap
$6,660
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
9.37
52-Wk Range
0.000001-0.0001
CEO
Jeffrey Yapp
Country
CA
Currency
USD

Chalice Brands Ltd operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Portland, OR, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $6,660. On trailing twelve-month figures it carries a trailing P/E of 0.00, a net margin of 0.0%. Its beta of 9.37 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
0.00
Price / Sales
0.00
Price / Book
0.00
EV / EBITDA
0.82
Gross margin
43.0%
Operating margin
43.0%
Net margin
0.0%
Return on equity
Debt / equity
2.04
Current ratio
0.53
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
98
IPO date
2016-02-18
Headquarters
Portland, OR, CA
About Chalice Brands Ltd

Chalice Brands Ltd. is engaged in the development, processing, and distribution of medical cannabis products. The firm offers products under the Golden XTRX, Proper, and Left Coast Connection brands. It's brands include Chalice Farms, Golden, Jackpot, Elysium Fields, and RXO (RSO+GO). The company was founded on April 12, 2011 and is headquartered in Toronto, Canada.

Comparable companies

Chalice Brands Ltd is most often compared with the following Healthcare names:

DSKYFDSNKYHLNCFHOCPFIPSEYLZAGFMKGAFMKKGYTKPHFWUXIF
More research on CHALF
CHALF technical analysis CHALF TheEdge Score Compare against peers
Open full interactive analysis & DCF →